Clinical Trial Update: Study To Evaluate Emtricitabine/Tenofovir Alafenamide (F/TAF) in Human Immunodeficiency Virus 1 (HIV-1) Infected Children and Adolescents Virologically Suppressed on a 2-Nucleoside/Nucleotide Reverse Transcriptase Inhibitor (2-NRTI)-Containing Regimen [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluated emtricitabine/tenofovir alafenamide (F/TAF) in HIV-1 infected children and adolescents who were virologically suppressed on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Emtricitabine/Tenofovir Alafenamide (emtricitabine/tenofovir alafenamide)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV-1 | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-01-12